Medifast/MED

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Medifast

Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.

Ticker

MED

Sector

Consumer Non-Cyclicals

Trading on

NYSE

Industry

Biotechnology & Drugs

CEO

Daniel Chard

Employees

634

Headquarters

Owings mills, United States

Medifast Metrics

BasicAdvanced
$282M
Market cap
4.15
P/E ratio
$6.20
EPS
1.18
Beta
$3.30
Dividend rate
12.82%
Dividend yield
$282M
1.18412
$109.52
$22.35
464K
$3.30
2.845
2.245
54.05%
6.137
21.71%
35.49%
32.62%
4.151
0.314
1.334
1.334
9.351
3.59%
12.82%
-41.32%
-51.45%
4.67%
1.60%
3.08%

What the Analysts think about Medifast

Analyst Ratings

Majority rating from 2 analysts.
Hold

Medifast Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
4.75% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$175M
-8.53%
Net income
$8.3M
38.33%
Profit margin
4.75%
51.27%

Medifast Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 15.38%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.77
$2.12
$0.55
$0.66
-
Expected
$1.44
$1.07
$0.96
$0.78
$0.33
Surprise
92.36%
99.06%
-42.71%
-15.38%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Medifast stock?

Medifast (MED) has a market cap of $282M as of June 15, 2024.

What is the P/E ratio for Medifast stock?

The price to earnings (P/E) ratio for Medifast (MED) stock is 4.15 as of June 15, 2024.

Does Medifast stock pay dividends?

Yes, the Medifast (MED) stock pays dividends to shareholders. As of June 15, 2024, the dividend rate is $3.3 and the yield is 12.82%. Medifast has a payout ratio of 54.05% on a trailing twelve-month basis.

When is the next Medifast dividend payment date?

The next Medifast (MED) dividend payment date is unconfirmed.

What is the beta indicator for Medifast?

Medifast (MED) has a beta rating of 1.18. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Medifast stock price target?

The target price for Medifast (MED) stock is $25, which is NaN% below the current price of $. This is an average based on projections from 2 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Medifast stock

Buy or sell Medifast stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing